1-2 of 2
Mei Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses

Available to Purchase
Yong Huang, Xiao Yang, Jing Li, Weilin Zhou, Fengling Wang, Jiaqian Li, Yalan Zhang, Feiyang Yan, Haozhan Gao, Xinyu Gu, Sha Luo, Yuening Yang, Mei Liu, Xiao Liang, Lin Jiang, Maorong Fu, Jinhua Su, Yuquan Wei, Wei Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2025) 24 (7): 1075–1087.
https://doi.org/10.1158/1535-7163.MCT-24-0597
Published: 02 July 2025
View article titled, CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
Open the PDF for CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses in another window
Includes: Supplementary data
Journal Articles

Preclinical In vivo Evaluation of Efficacy, Pharmacokinetics, and Pharmacodynamics of a Novel MEK1/2 Kinase Inhibitor RO5068760 in Multiple Tumor Models

Free
Sherif Daouti, Brian Higgins, Kenneth Kolinsky, Kathryn Packman, Huisheng Wang, Christine Rizzo, John Moliterni, Nicholas Huby, Nader Fotouhi, Mei Liu, Petra Goelzer, Harpreet K. Sandhu, Jia Kui Li, Aruna Railkar, David Heimbrook, Huifeng Niu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (1): 134–144.
https://doi.org/10.1158/1535-7163.MCT-09-0601
Published: 12 January 2010
View article titled, Preclinical In vivo Evaluation of Efficacy, Pharmacokinetics, and Pharmacodynamics of a Novel MEK1/2 Kinase Inhibitor RO5068760 in Multiple Tumor Models
Open the PDF for Preclinical In vivo Evaluation of Efficacy, Pharmacokinetics, and Pharmacodynamics of a Novel MEK1/2 Kinase Inhibitor RO5068760 in Multiple Tumor Models in another window
Includes: Supplementary data